Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001493152-15-003696

← back to feed
Filed
Aug 14, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 13, 2015 14.16M sh
Stockholders Equity Q2 2015 · Jun 30, 2015 $337.99K
Stockholders Equity Q2 2015 · Dec 31, 2014 $268.19K
Current Liabilities Q2 2015 · Jun 30, 2015 $327.79K
Current Liabilities Q2 2015 · Dec 31, 2014 $448K
Current Assets Q2 2015 · Jun 30, 2015 $665.78K
Current Assets Q2 2015 · Dec 31, 2014 $716.19K
Total Assets Q2 2015 · Jun 30, 2015 $665.78K
Total Assets Q2 2015 · Dec 31, 2014 $716.19K
Operating Cash Flow Q2 2015 · Jun 30, 2014 −$973.36K
Sga Expense Q2 2015 · Jun 30, 2014 $6.7K
Sga Expense Q2 2015 · Jun 30, 2014 $14.46K
Rd Expense Q2 2015 · Jun 30, 2014 $616.75K
Rd Expense Q2 2015 · Jun 30, 2014 $746.54K
Net Income Q2 2015 · Jun 30, 2014 −$958.71K
Net Income Q2 2015 · Jun 30, 2014 −$1.16M
Operating Income Q2 2015 · Jun 30, 2014 −$958.91K
Operating Income Q2 2015 · Jun 30, 2014 −$1.16M